• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Senores Pharmaceuticals Limited — Board Meeting, 20-01-2026: Outcome of Board Meeting

    20-01-2026 | 01:31 pm

    Senores Pharma's board approved strong Q3 & 9M FY26 consolidated results. Q3 saw Total Income hit ₹175 Cr (+64% Y-o-Y) and PAT surge to ₹34 Cr (+105% Y-o-Y). The company also confirmed 75% acquisition of Apnar Pharmaceuticals, boosting regulated market growth and new product launches.

    No comments yet. Be the first to comment!

    All announcements from Senores Pharmaceuticals Limited